StonvexLoading…
StonvexCore line items from AMPX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $71.91M | $23.57M | $8.79M |
Operating Income | $-46.65M | $-46.26M | $-38.71M |
Net Income | $-44.02M | $-44.67M | $-36.78M |
EPS (Diluted) | $-0.35 | $-0.45 | $-0.43 |
Total Assets | $156.89M | $121.13M | $107.74M |
Total Liabilities | $53.08M | $51.65M | $47.94M |
Cash & Equivalents | $90.47M | $55.16M | $45.76M |
Free Cash Flow OCF − CapEx | $-35.53M | $-36.56M | $-43.10M |
Shares Outstanding | 134.54M | 116.93M | 88.87M |